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1. Introduction  
Since its first description in 1874 by Charcot, the hallmark feature of ALS is the progressive 
degeneration of upper and lower motoneurons (Charcot, 1874). In the spinal cord, 
motoneuron degeneration starts long before symptom onset and advances in a size-related 
fashion, in which large-size alpha-motoneurons degenerate first followed by small-size 
alpha-motoneurons (Pun et al., 2006; Hegedus et al., 2007; Hegedus et al., 2008). There are 
conflicting reports regarding the survival of the smallest-sized spinal motoneurons, the 
gamma-motoneurons (Swash and Fox, 1974; Sobue et al., 1981). Despite its original 
description, the neuronal degeneration in ALS is not limited to motoneurons. Recent reports 
have shown evidence for degeneration of neurons in the brain (Karim et al., 1998; Lloyd et 
al., 2000; Maekawa et al., 2004) and interneurons in the spinal cord (Konno et al., 1986; 
Williams et al., 1990; Takahashi et al., 1993; Stephens et al., 2006).  
Before their degeneration, spinal motoneurons experience progressive changes in their 
properties. These changes result from the pathological actions of the disease and the 
compensatory mechanisms of the nervous system to mitigate the neuronal malfunction. In this 
chapter, we describe the changes in the anatomical and electrical properties of spinal 
motoneurons in various genetic mouse models of ALS and critically analyze literature for the 
common and different pathological features across these models. We also present data from 
computer simulations showing the consequences of the alterations in properties of mutant 
motoneurons on cell excitability and dendritic processing of synaptic inputs. The presented 
computational analysis allowed for the identification of motoneuron alterations undetectable 
using standard electrophysiological methods. This information is essential for understanding 
motoneuron pathophysiology in ALS. 
2. The changes in motoneuron anatomical properties 
One of the earliest abnormalities in transgenic mouse models of ALS is the change in 
anatomy of spinal motoneurons. In the G85R model, it has been shown that mutant 
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motoneurons exhibit an increase in the overall cell size and branching pattern of dendrites 
(Amendola et al., 2007; Amendola and Durand, 2008). These changes appear in transgenic 
mice at 10 days after birth (P10), long before disease onset and life end-stage (225 and 240 
days, respectively) (Bruijn et al., 1997). More specifically, in mutant motoneurons the total 
dendritic surface area and total dendritic length are increased by 58% and 65% relative to 
wild-type (WT) cells, respectively. For dendritic branching, the number of dendritic 
branches, terminal branches, branching nodes, and maximum branching order are 
increased by 93%, 89%, 97%, 37%, respectively (Fig. 1). On the other hand, the soma size 
(diameter and surface area) and primary dendrites properties (number, diameter, and 
cross-sectional area) are similar in WT and mutant motoneurons. Interestingly, the 
increase in number of branches occurs primarily in short branches (dendritic branches 
with path length < 100µm) and most of the anatomical changes take place over the middle 
dendrites (200µm - 500µm from the soma). Surprisingly, the longest dendritic length from 
the soma was not increased in mutant motoneurons, indicating that dendritic 
overbranching occurs mainly within the cell circumjacent. In other words, the cell does 
not swell into larger space in the cord but develops more branching within its dendritic 
spatial field. 
 
 
Fig. 1. Anatomical alterations in mutant motoneurons of the G85R (reconstructed from the 
whole-cord prep1) and G93A (high expressor line) (reconstructed from the slice prep.) 
transgenic models relative to WT cells. 1: data from Amendola and Durand (2008). 
Similar early abnormalities in the anatomical properties of motoneurons have been found 
in other transgenic mouse models of ALS. In the G93A (low expressor line), which 
expresses 8 copies of the human SOD1 gene, mutant motoneurons at P9 exhibit increased 
cell size, dendritic overbranching, and dendritic complexity (Filipchuk et al., 2010). The 
total dendritic length and number of branching nodes and terminal dendrites in mutant 
motoneurons were significantly increased relative to WT. Similar to the G85R transgenic 
model, these anatomical changes in the G93A (low expressor line) model occur early in 
the disease (at P9) way before symptom development (between 195 and 240 days) and end 
stage (between 240 and 270 days). Preliminary data from our laboratory obtained in the 
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slice preparation show that neonatal mutant motoneurons (P7) of the G93A (high 
expressor line), which expresses 25 copies of the human SOD1 gene, experience analogous 
alterations in their morphology and dendritic branching (Fig. 1), in which the soma 
surface area, numbers of dendritic branches and terminal dendrites increase significantly 
relative to WT. 
Post-mortem morphological analysis of large neurons in the ventral horn of spinal cord 
indicated an increase in the initial segment diameter, by 36%, in ALS patients (Sasaki and 
Maruyama, 1992). Conversely, the soma area of these neurons was smaller by 16% relative 
to control (Sasaki and Maruyama, 1992).  
The similar findings on the anatomical alterations of neonatal motoneurons in various 
transgenic models of ALS indicate that the increase in cell size and dendritic overbranching 
are characteristic abnormalities in motoneuron pathophysiology in ALS. However, it is 
unclear whether the alteration in motoneuron anatomy is a disease mechanism or an 
adaptive response (see section 7 for discussion). Furthermore, it is important to understand 
the functional ramifications of the motoneuron anatomical alterations on the cell excitability 
and electrical properties and to what extent the anatomical alterations contribute to 
motoneuron degeneration in ALS (see section 6).  
3. The changes in motoneuron electrical properties 
3.1 The change in input resistance 
Changes in a number of motoneuron electrical properties were reported in the transgenic 
mouse models of ALS. However, one challenge in the field of ALS is the large variability in 
data of mutant motoneuron electrical properties, which makes recording from a large 
number of cells is important to allow statistical tests to detect significant differences in 
electrophysiological properties between WT and mutant motoneuron samples. Table 1 
summarizes the changes in electrical properties of mutant motoneurons observed in the 
various ALS transgenic mouse models. The summary shows that the changes in electrical 
properties involve the motoneuron passive properties (e.g., cell input resistance), the size 
and shape of the action potential spike and afterhyperpolarization, the amplitude of voltage-
sensitive ionic currents, and the motoneuron excitability and firing activity. However, some 
of these changes were inconsistent (i.e., not observed consistently) across the ALS transgenic 
models, whereas others were contradictory (i.e., opposite changes were observed). For 
instance, the decrease in input resistance of mutant motoneurons relative to WT is an 
inconsistent finding in ALS transgenic models (see table 1, column 7). This observation was 
seen in some studies (Bories et al., 2007; ElBasiouny et al., 2010; Quinlan et al., 2011), 
whereas other studies did not find a statistically significant difference between the input 
resistance of WT and mutant motoneurons (Pieri et al., 2003; Kuo et al., 2004; Kuo et al., 
2005; van Zundert et al., 2008; Pambo-Pambo et al., 2009; Pieri et al., 2009; Filipchuk et al., 
2010; Meehan et al., 2010). The changes in action potential size and width in mutant 
motoneurons, on the other hand, is a conflicting finding in which some studies reported an 
increase in spike height (van Zundert et al., 2008) and duration (Fuchs et al., 2008, 2009; 
Pambo-Pambo et al., 2009) relative to WT, whereas others reported reduction in spike height 
(Kuo et al., 2004; Pambo-Pambo et al., 2009; Filipchuk et al., 2010) and duration (Pieri et al., 
2003; Quinlan et al., 2011). 
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Table 1. Summary of the alterations in mutant motoneuron properties. SMNs: spinal motoneurons, CNs
HGMNs: hypoglossal motoneurons, OMNs: ocular motoneurons, OINs: ocular interneurons. [Ca2+]
concentration, Rin: input resistance, Vrest: resting membrane potential, AP: action potential, AHP: aft
persistent inward current, F-I: frequency-current relationship.  VC: voltage-clamp, ΔI: the difference in 
motoneuron recruitment and de-recruitment on a triangular current command, No diff: no differenc
w
w
w
.intechopen.com
  
Amyotrophic Lateral Sclerosis 
 
162 
3.1.1 Effect of tissue preparation 
The discrepancy in the changes of electrical properties of mutant motoneurons probably 
results partially from the differences in transgenic model types (e.g., G85R, G93A high or 
low expressor lines) and is compounded by the variability in experimental conditions such 
as animal age (e.g., neonatal, pre- or post-symptomatic adult motoneurons) and tissue 
preparation (e.g., cell culture, slice, whole-cord, or in-vivo), in addition to the recording 
conditions (e.g., extracellular Ca2+ concentrations) and measurement methods (current- or 
voltage-clamp). However, critical analysis of the changes in electrical properties of mutant 
motoneurons shows that common pathological features could be identified across the 
various ALS transgenic models, whereas other features could be related to experimental 
conditions. For instance, the decrease in input resistance was detected mainly in studies 
conducted on the whole-cord preparation (in which the brainstem and spinal cord are 
intact), but was not observed in studies on motoneurons in cell culture or slice preparations 
(Table 1). Because input resistance is an indirect measure of cell size, it becomes reduced in 
mutant motoneurons to reflect the enlargement in motoneuron anatomy discussed in the 
previous section. In the whole-cord preparation, the motoneuron dendrites are completely 
intact and their effect on input resistance is more easily detected. In the slice preparation, 
conversely, the motoneuron dendrites are truncated at the surface of the slice. The lack of 
the middle and distal portions of dendrites could mask the anatomical differences between 
WT and mutant motoneurons and would explain the disappearance of input resistance 
differences between WT and mutant motoneurons in the slice preparation. Table 2 shows a 
comparison of the input resistance values of neonatal motoneurons in the various transgenic 
models of ALS. In the G85R and G93A (low expressor line) models, the input resistance 
values in the whole-cord preparation (ElBasiouny et al., 2010; Filipchuk et al., 2010) were on 
average half of those in the slice preparation (Pambo-Pambo et al., 2009), indicating that 
nearly half of the dendrites were severed in the slice preparation. Strikingly, the decrease in 
input resistance of mutant motoneurons of the G93A (high expressor line) model was still 
detected in the slice preparation in Quinlan et al. (2011). This could indicate that the 
motoneuron anatomical alterations in the G93A (high expressor line) model are so extensive 
that they were still substantial in the slice preparation and/or the motoneuron membrane 
biophysical properties change considerably in the G93A (high expressor line) model and 
contribute significantly to the decrease in input resistance (see section 4). For cell culture, 
given that the trigger signal for the alteration in motoneuron anatomy is poorly understood 
and could result from the alteration in motoneuron excitability and synaptic inputs (Duch et 
al., 2008), mutant motoneurons in the cell culture preparation might not experience 
anatomical alterations due to their isolation (in the cell culture) from the pathological neural 
circuit (in the transgenic mouse spinal cord), leading to absence of differences in input 
resistance between WT and mutant motoneurons.  
3.1.2 Effect of extracellular Ca2+ concentration 
The measurement of input resistance values, and other electrical properties, in mutant 
motoneurons also depends on the extracellular concentration of Ca2+ ions in the recording 
solution. For instance, the input resistance value of neonatal motoneurons of the G85R 
model measured in 4mM of extracellular Ca2+ concentration (Bories et al., 2007) was double 
of that measured in 2mM of extracellular Ca2+ concentration (ElBasiouny et al., 2010) (see 
table 2). Although 2mM is typical, the variability in extracellular Ca2+ concentration (ranging 
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between 2mM and 4mM, see table 1) among the various ALS studies could contribute to the 
discrepancies in electrical properties of mutant motoneurons. This effect is produced 
because the level of extracellular Ca2+ concentration modulates the magnitude of the 
motoneuronal Ca2+-gated (e.g., Cav 1.2, 1.3, and 2.2 channels) and Ca2+-activated (e.g., SK 
and Ih channels) ionic currents, which regulate the motoneuron firing activity and affect the 
action potential and afterhyperpolarization properties.  
 
Model Publication Preparation [Ca2+]o 
Rin 
WT/SOD1 
Anatomical 
alterations 
G93A 
(high) 
Quinlan et al. 
(2011) 
Slice 2mM 
38.5/31.3 MΩ 
(↓ by 19%)* Yes1 
G85R 
Bories et al. 
(2007) 
Whole-cord 4mM 
33.3/23.8 MΩ 
(↓ by 29%)* 
Yes2 
ElBasiouny et al. 
(2010) 
Whole-cord 2mM 
16.2/11.4 MΩ 
(↓ by 30%)* 
Pambo-Pambo et 
al. (2009) 
Slice 2mM 
34.5/33.1 MΩ 
ns 
G93A 
(low) 
Pambo-Pambo et 
al. (2009) 
Slice 2mM 
34.5/37.2 MΩ 
ns 
Yes3 
Filipchuk et al. 
(2010) 
Whole-cord 2mM 
18.5/16.1 MΩ 
ns 
Table 2. Comparison of the change in input resistance in mutant motoneurons (P6-P10) in 
the various ALS transgenic models. 1: unpublished data, 2: Amendola and Durand (2008), 3: 
Filipchuk et al. (2010), *: statistically-significant (p<0.05), ns: not statistically-significant.  
In sum, the reduction in input resistance of mutant motoneurons is a common, early 
pathological feature in the G93A (high expressor line) and G85R transgenic models, but not 
in the G93A (low expressor line). Also, this abnormality might sometimes not be evident 
depending on the tissue preparation used in the experiment. 
3.2 The changes in action potential and afterhyperpolarization 
A change in the action potential properties was frequently seen in mutant motoneurons 
relative to WT; however, these changes were conflicting across the transgenic models (Table 
1, Fig. 2). In the G93A (high expressor line) model, neonatal spinal motoneurons frequently 
showed faster action potential rate of rise and decay and shorter action potential duration 
(Pieri et al., 2003; Quinlan et al., 2011), indicating an increase in transient and persistent Na+ 
currents, which act to increase the excitability of mutant motoneurons. Signs of increased 
excitability were differently displayed in other studies as an increase in spike height (van 
Zundert et al., 2008), depolarization in resting membrane potential (Kuo et al., 2005), or 
reduction in action potential threshold (Pieri et al., 2009). Conversely, an increase in action 
potential duration and deceleration in rate of repolarization were observed in post-
symptomatic adult hypoglossal motoneurons (Fuchs et al., 2009).  
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Fig. 2. The changes in action potential height (APamp), maximum rise (APmax rise) and fall 
(APmax fall) rates, and AHP amplitude (AHPamp) and half-width (AHPhalf-width) in mutant 
motoneurons of the G93A (high expressor line) [2nd bars]1, G93A (high expressor line) [3rd 
bars]2, and the G85R [last bars]2 transgenic models, relative to WT [1st bars]. All reported 
data from slice preparation. 1: Quinlan et al. (2011), 2: Pambo-Pambo et al. (2009). 
In the G93A (low expressor line) model, neonatal spinal motoneurons exhibited a reduction 
in action potential height, increase in half-width, and deceleration in the rates of rise and 
decay (Pambo-Pambo et al., 2009; Filipchuk et al., 2010). In the G85R model, no changes 
were observed in the properties of the action potential regardless of the tissue preparation 
(whole-cord or slice) and extracellular Ca2+ concentration (2mM or 4mM) (Bories et al., 2007; 
Pambo-Pambo et al., 2009; ElBasiouny et al., 2010). Therefore, it appears that the alteration in 
action potential properties is not a common pathological characteristic, but depends on the 
ALS transgenic model type.  
The after-spike afterhyperpolarization was not consistently altered in mutant motoneurons 
across the various transgenic models (Table 1, Fig. 2). 
3.3 The change in persistent inward currents 
Persistent inward currents are intrinsic Na+ and Ca2+ currents that depolarize the 
membrane potential when activated. Contrary to transient ionic currents, these currents 
do not inactivate with prolonged membrane depolarization (Schwindt and Crill, 1977). A 
change in the motoneuron persistent inward current was frequently observed in mutant 
motoneurons (Table 1, Fig. 3); however, conflicting data were reported on the nature of 
this change (i.e., increase or decrease). In the G93A (high expressor line) model, an 
increase in the Na+ persistent inward current of neonatal mutant motoneurons was 
consistently reported regardless of tissue preparation (cell culture and slice) or 
extracellular Ca2+ concentration (Table 1). In the G93A (low expressor line) and G85R 
models, persistent inward current measured in voltage-clamp protocols indicated no 
change in their amplitude between WT and mutant motoneurons, whereas persistent 
inward current estimated from the delta I (ΔI) technique indicated a reduction in their 
amplitude in mutant motoneurons relative to WT (Pambo-Pambo et al., 2009). The 
former is a more truthful result because voltage-clamp protocols allow direct 
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measurement of the persistent inward current, whereas the ΔI technique (which is 
obtained from the difference in injected current at motoneuron recruitment and de-
recruitment on a triangular current command) provides an indirect estimate of the 
persistent inward current amplitude (Bennett et al., 2001) and is sensitive to the 
inactivation of transient Na+ channels (Miles et al., 2005) and activation of residual 
outward currents present in the motoneuron membrane (Hamm et al., 2010). However, it 
should be noted that the number of cells in which the voltage-clamp measurements were 
obtained was small. In the infrequently studied G127X transgenic model, an increase in 
the persistent inward current amplitude was estimated from the motoneuron firing 
profile (Meehan et al., 2010). However, this result is unconfirmed given that firing profile 
in mutant motoneurons would be also influenced by any differences in inward or 
outward currents and electrical properties of mutant motoneurons. Accordingly, the 
change in amplitude of persistent inward currents is not a common abnormality in the 
various ALS transgenic models. However, it appears that persistent inward currents are 
increased only in the G93A (high expressor line) transgenic model. 
 
 
Fig. 3. The changes in ramp frequency-current relationship gain (ramp F-Igain), sodium 
(NaPIC) and calcium (CaPIC) persistent inward currents in mutant motoneurons of the 
G93A (high expressor line) [2nd bars]1, G93A (high expressor line) [3rd bars]2, and the G85R 
[last bars]2 transgenic models, relative to WT [1st bars]. All reported data from slice 
preparation. 1: Quinlan et al. (2011), 2: Pambo-Pambo et al. (2009). 
3.4 The change in motoneuron gain and firing activity 
A change in the motoneuron gain (i.e., F-I relationship slope) or firing activity was 
commonly seen in mutant motoneurons, but conflicting observations were also reported. In 
the G93A (high expressor line) transgenic model, the firing activity and gain of mutant 
spinal motoneurons were consistently increased in cell culture (Pieri et al., 2003; Kuo et al., 
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2004; Kuo et al., 2005; Zona et al., 2006; Pieri et al., 2009), but not in the slice (Quinlan et al., 
2011) (Table 1). In the G85R transgenic model, the gain of mutant motoneurons was 
consistently reduced relative to WT (Bories et al., 2007; Pambo-Pambo et al., 2009). In the 
G93A (low expressor line) transgenic model, the gain of mutant motoneurons was increased 
in the slice preparation (Pambo-Pambo et al., 2009), but did not change in the whole-cord 
preparation (Filipchuk et al., 2010). The disagreement in reports on the change in 
motoneuron gain in the various transgenic models could be partially due to the variation in 
tissue preparation and extracellular Ca2+ concentration. Motoneuron dendrites have active 
conductances, which influence the motoneuron gain. Therefore, the portion of the 
motoneuron dendrites available during recording in the slice preparation would indirectly 
affect the measurement of the motoneuron gain in WT and mutant motoneurons. Also, the 
effect of extracellular Ca2+ concentration on the amplitude of Ca2+–activated and Ca2+–gated 
currents would influence the motoneuron gain measurement based on the degree of 
existence of these channels in WT and mutant motoneurons. Taken collectively, the change 
in gain and firing activity of mutant motoneurons is inconsistent within and across the 
various ALS transgenic models. 
3.5 Motoneuron excitability in the various ALS transgenic models 
Despite the discrepancy in data on the excitability of mutant motoneurons in the various 
ALS transgenic models, some insights could be attained from the trend in electrical 
properties change (Table 3). In the G93A (high expressor line) model, most changes in 
electrical properties push toward increased excitability of mutant motoneurons. For 
instance, the increases in action potential height and rise and decay rates and the 
reduction in action potential width are signs of elevated transient and persistent Na+ 
currents that enhance the motoneuron excitability of mutant motoneurons. Also, the 
increase in persistent inward current amplitude further acts to enhance the motoneuron 
excitability. Collectively, these mechanisms push toward increased excitability of mutant 
motoneurons (i.e., excitability enhancement mechanisms). On the other hand, the increase 
in motoneuron size and reduction in input resistance are mechanisms that counteract 
increased excitability (i.e., excitability suppressive mechanisms) because the motoneuron 
becomes harder to recruit. It is unclear whether the excitability enhancement or 
suppressive mechanisms are disease or compensatory processes; however, the net effect 
of these mechanisms is increased excitability (i.e., hyperexcitability) of mutant 
motoneurons in the G93A (high expressor line) model (Table 3). This supposition is 
supported by the numerous reports on increased gain, although from cultured 
motoneurons, of mutant motoneurons in this transgenic model.  
In the G93A (low expressor line) model, all changes in electrical properties indicate a 
reduction in the excitability of mutant motoneurons (i.e., hypoexcitability) (Table 3). These 
changes involve increase in motoneuron size, reduction in input resistance, smaller and 
broader action potential spikes, and slower rise rate (Table 3). The last two observations are 
indicative of a decrease in transient and persistent Na+ currents in mutant motoneurons 
relative to WT. In contrast to these data, the gain of mutant motoneurons measured using 
long pulses was higher than that of WT motoneurons; however, the gain measured using 
current ramp was not different from WT motoneurons (Pambo-Pambo et al., 2009). Taken 
collectively, more evidence is available on reduced excitability of mutant motoneurons in 
the G93A (low expressor line).  
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Model 
MN 
size 
Rin AP/AHP PIC Gain Excitability 
G93A 
(high) 
↑↑ ↓↓ 
Higher & briefer 
spikes 
Faster rise & decay 
rates 
↑↑ ↑↑/-- Hyperexcitability 
G93A 
(low) 
↑↑ -- 
Smaller & broader 
spikes 
Slower rise & decay 
rates 
-- ↑↑/-- More evidence on 
hypoexcitability 
G85R ↑↑ ↓↓ -- -- ↓↓ Hypoexcitability 
Table 3. Summary of changes in motoneuron properties in the various ALS transgenic 
models. MN: motoneuron, Rin: input resistance, AP/AHP: action potential and 
afterhyperpolarization, ↑↑: increase, ↓↓: decrease, --: no change.  
In the G85R transgenic model, not many changes were reported in the electrical properties 
of mutant motoneurons; however, these changes were consistent with reduced excitability 
and are supported by the decrease in gain of mutant motoneurons (Table 3). In conclusion, 
motoneuron pathophysiology is different in the various transgenic mouse models of ALS 
and their excitability varies from hypo- to hyperexcitability. This disparity could be related 
to the number of copies of the human SOD1 gene  or the severity of the disease (transgenic 
models with high copy number of SOD1 genes have more aggressive ALS than transgenic 
models with low copy number of SOD1 genes). Transgenic models with a low number of 
SOD1 copies (e.g., G85R and G93A-low expressor line) showed a tendency for reduced 
excitability of mutant motoneurons, whereas transgenic models with a high number of 
SOD1 copies (e.g., G93A-high expressor line) showed a tendency for increased excitability of 
mutant motoneurons. These differences should be considered when studying the 
motoneuron pathophysiology in these ALS transgenic models.  
4. Effect of anatomical alterations on motoneuron electrical properties 
The enlarged anatomy of mutant motoneurons has consequences for their electrical 
properties and firing behaviour. Computer simulations have been used to assess the effect 
of enlargement in motoneuron anatomy and its contribution to the changes in electrical 
properties (ElBasiouny et al., 2010). Realistic computer models were developed from the 
reconstructed morphologies of WT and mutant motoneurons of the G85R model and were 
optimized to replicate the electrophysiological recordings obtained from individual cells. 
For the 30% reduction in input resistance of mutant motoneurons relative to WT, 
computer simulations showed that one third of this reduction (i.e., input resistance 
decrease by 10%) is due to the enlargement of motoneuron anatomy, whereas two thirds 
of this reduction (i.e., input resistance decrease by additional 20%) is due to a decrease in 
the specific membrane resistance of the motoneuron membrane. The specific membrane 
resistance represents the number of leak channels available in a patch of cell membrane 
and its decrease means that there are more ion channels inserted into the membrane (i.e., 
the cell has higher conductance). Comparison of WT and mutant motoneuron models 
www.intechopen.com
  
Amyotrophic Lateral Sclerosis 
 
168 
indicated a 25% decrease in the somatic and dendritic specific membrane resistance of the 
mutant models. Therefore, the simulation results indicate that the enlargement in 
motoneuron anatomy does not fully account for the reduction in input resistance as 
previously suggested by Bories et al. (2007). This is because the additional dendritic 
branches causing the increased surface area are electrotonically distant from the soma, the 
site of input resistance measurement. This electrotonic separation reduces the influence of 
the additional dendritic area at the soma. Thus, a 60% increase in total surface area of 
mutant motoneurons causes only a 10% decrease in cell input resistance (not 40% as 
would be predicted from the reciprocal of surface area increase of an electrotonically 
compact sphere). Secondly, the simulation results indicate that the reduction in input 
resistance of mutant motoneurons is a function of two factors: the enlargement in 
motoneuron anatomy and the decrease in specific membrane resistance; the weights of 
these factors determine the magnitude of input resistance reduction. This could explain 
why the enlargement of motoneuron anatomy was not always associated with reduction 
in input resistance as in the case of the G93A (low expressor line) model (see Table 2), 
suggesting an insignificant change in the membrane specific membrane resistance in this 
transgenic model. In contrast, the significant reduction in input resistance of mutant 
motoneurons of the G93A (high expressor line) model despite the truncation in 
motoneuron dendrites in the slice preparation in Quinlan et al. (2011) might indicate a 
substantial change in the specific membrane resistance in that transgenic model.  
The effects of enlargement in mutant motoneuron anatomy are not only limited to cell input 
resistance, but also extend to cell firing properties. For instance, the enlargement in mutant 
motoneuron anatomy would be expected to cause reductions in the motoneuron F-I gain 
and initial and maximum firing rates and increases in rheobase current and total cell 
capacitance. Given that no change was seen in some of these properties of mutant 
motoneurons indicate that compensatory mechanisms have masked those effects (e.g., 
upregulation in motoneuron transient and persistent inward currents). Estimating the 
contribution of anatomy enlargement to the changes in mutant motoneurons firing activity 
and identifying potential ionic mechanisms for masking these changes using computer 
simulations would be an important step in revealing hidden alterations in motoneuron 
properties and improving our understanding of ALS pathogenesis. 
5. The changes in synaptic inputs to motoneurons 
In ALS patients and transgenic models, synaptic inputs converging onto motoneurons 
experience changes during disease progression. These changes involve loss of specific 
types of synaptic inputs, rearrangement of the synaptic contacts, and alteration in the size 
of synaptic boutons. For instance, it has been shown that cholinergic synapses on lumbar 
motoneurons are lost in ALS patients (Nagao et al., 1998). This loss starts before 
motoneuron degeneration. Given that cholinergic synapses provide inhibitory input to 
motoneurons (Nagy et al., 1993), their loss could alter the balance toward more excitatory 
inputs, leading to motoneurons overactivation. This prediction has been confirmed in 
G93A (high expressor line) transgenic mice in which the ratio of inhibitory to excitatory 
synapses was reduced due to the loss of inhibitory boutons (loss was mediated by nitric 
oxide) and increase in excitatory boutons (Sunico et al., 2011). Furthermore, residual 
inhibitory boutons exhibit shorter active zone length and smaller synaptic vesicle density 
(Sunico et al., 2011). Along the same line, there was a progressive increase in the 
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excitability of interneurons, through NMDA receptors, that starts in the presymptomatic 
stage of ALS (Jiang et al., 2009).  
Computer simulations of mutant motoneuron models predicted a reduction in the efficacy 
of dendritic processing of synaptic inputs early in ALS (ElBasiouny et al., 2010). The 
amplitude of somatic excitatory postsynaptic potentials (EPSPs) was reduced in mutant 
motoneurons by 15%, relative to WT. This reduction was comparable to experimental 
measurements of EPSP amplitudes in the G85R transgenic model (Bories et al., 2007). The 
computer simulations showed that the reduction in EPSP amplitude resulted from the 
alteration in various motoneuron properties such as: the increase in motoneuron 
morphology, the decrease in specific membrane resistance, and the increase in dendritic 
active conductance activation. The changes in these properties counteract each other and 
produce the net reduction in EPSP amplitude. These changes were consistent in synaptic 
inputs with different dynamics (i.e., slow and fast inputs) (ElBasiouny et al., 2010). 
6. The functional ramifications of the alteration in motoneuron properties 
The combined changes in motoneuron properties (anatomical, electrical, biophysical) and 
synaptic inputs converging on them in ALS alter the input-output function of mutant 
motoneurons and affect their recruitment. For instance, the reduction in input resistance of 
mutant motoneurons makes them harder to recruit. Similarly, the enlargement in 
motoneuron anatomy and development of dendritic overbranching increase the attenuation 
of excitatory and inhibitory post synaptic potentials as they flow to the soma along the 
dendrites and reduce their efficacy. Computer simulations of reconstructed morphologies of 
WT and mutant motoneurons indicated a reduction in the efficacy of slow and fast synaptic 
inputs (by ≈20%) in mutant motoneurons (ElBasiouny et al., 2010). Half of this efficacy 
reduction was due to the dendritic overbranching, whereas the second half was due to the 
decrease in specific membrane resistance, leading to increased signal loss through leak 
conductances. The simulations demonstrated that reduction in synaptic efficacy was still 
present despite the upregulation in the dendritic active conductances mediating persistent 
inward current. These combined reductions in cell input resistance and synaptic input 
efficacy push toward reduced excitability of the cell. It is unclear whether these changes 
represent disease or protective mechanisms (see next section for discussion).  
7. Anatomical alterations versus excitability changes: Disease versus 
neuroprotective mechanisms? 
The individual changes seen in properties of mutant motoneurons could be a disease 
mechanism, which produces a physiological malfunction, or a neuroprotective (i.e., 
compensatory) mechanism of the nervous system, which mitigates the physiological 
malfunction caused by the disease. These mechanisms develop sequentially and act 
antagonistically. Given that ALS pathogenesis is still poorly understood (i.e., disease 
mechanisms are not identified yet), it is unfeasible to categorize the changes in mutant 
motoneurons to disease or compensatory mechanisms with assertion; however, some 
hypotheses could be formulated from available data regarding the nature of these changes. 
For instance, the relationship between the alterations in anatomy and excitability of mutant 
motoneurons is paradoxical. In the G93A (high expressor line) model, the enlargement in 
motoneuron anatomy and concomitant increase in persistent inward current have opposite 
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actions on the excitability of motoneurons. Two hypotheses are described to infer the nature 
of these mechanisms. The first hypothesis is based on the effect of endurance training on 
healthy and transgenic mice. In healthy mice, endurance running exercise reduced the 
excitability of healthy motoneurons and increased their size, as suggested from their input 
resistance and cell capacitance measurements (Beaumont and Gardiner, 2002, 2003). In 
G93A mice, endurance running exercise reduced motor performance and shortened the life 
span of transgenic mice (Mahoney et al., 2004). Assuming that detrimental effects on 
transgenic mice would result from approaches that promote disease mechanisms, it is 
therefore plausible to suggest that anatomy enlargement of motoneurons is potentially an 
ALS disease mechanism. Consequently, the increase in motoneuron persistent inward 
current is potentially a compensatory mechanism to enhance the motoneuron excitability 
and offset the effect of enlarged anatomy. In this scenario, the additional dendrites would 
not possess active conductances and would reduce the motoneuron excitability by reducing 
the cell input resistance. However, this hypothesis is challenged by the beneficial effect of 
riluzole (the only FDA-approved drug available for ALS patients), which reduces 
motoneuron excitability and extends the life span of ALS patients (Bensimon et al., 1994; 
Miller et al., 1996) and transgenic mice (Gurney et al., 1998), suggesting increased 
excitability as the disease mechanism.  
The second hypothesis is based on the relationship between the intrinsic motoneuron 
excitability and dendrite anatomy. When potassium channels were genetically manipulated 
to increase or decrease the motoneuron excitability, the overall motoneuron size was 
increased in both conditions with increased dendritic branch formation in the former case or 
dendritic branch elongation in the latter (Duch et al., 2008). Given that the anatomical 
alterations seen in mutant motoneurons resemble some features of those produced in 
response to increased excitability, this suggests that anatomy enlargement of mutant 
motoneurons is potentially a compensatory mechanism, whereas the increase in 
motoneuron excitability is potentially the disease mechanism. In this scenario, the 
pathologically-formed dendrites could contribute to the disease-state by having dendritic 
active conductances, which would dramatically increase the magnitude of persistent inward 
currents and enhance the motoneuronal excitability. The reduction in input resistance of 
mutant motoneurons would result from the increase in cell size. This hypothesis is 
supported by the beneficial effect of riluzole on mutant motoneurons survival by 
suppressing their excitability as explained above. Because motoneuron hyperexcitability is 
not a common feature of ALS transgenic models (hyperexcitability appears in models with 
high copy number of SOD1 gene, Table 3), riluzole’s effect could be more pronounced in the 
more aggressive models of ALS that exhibit hyperexcitability, but less effective in the mild 
models of ALS (with less copy number of SOD1 gene) that exhibit hypoexcitability. This 
prediction might explain the discrepancy in studies on riluzole’s efficacy in the various ALS 
transgenic models (for review see Bellingham, 2011). More data are needed to divulge the 
nature of these mechanisms. 
In the G85R and G93A (low expressor line) models, alterations in anatomy and excitability 
of mutant motoneurons are observed, with no change in persistent inward current 
amplitude (Table 3). This disparity in the relationship between persistent inward current 
amplitude and motoneuron excitability in the various ALS transgenic models could be due 
to the difference in pace of disease progression in these models. In other words, disease and 
compensatory mechanisms advance at faster rates in aggressive ALS models (with high 
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copy number of SOD1 genes) than in mild ALS models (with low copy number of SOD1 
genes). This supposition is supported by the earlier disease onset and shorter life span in the 
G93A (high expressor line) than in the G85R and G93A (low expressor line) models (Turner 
and Talbot, 2008). Longitudinal studies in in-vivo mouse preparations in which the changes 
in motoneuron excitability, persistent inward currents, and anatomical properties in the 
various ALS transgenic models could be monitored at short time intervals during disease 
progression are needed to examine the development of these mechanisms.  
8. Conclusion 
Numerous alterations in the anatomical and electrical properties of mutant spinal 
motoneurons take place in the first two postnatal weeks, long before disease onset. Many of 
these alterations are inconsistent and sometimes contradictory; however, critical analysis of 
these alterations allowed for the identification of common pathological features within and 
across the various transgenic models of ALS. The enlargement in anatomy and reduction in 
input resistance of mutant motoneurons are characteristic features in the various transgenic 
models of ALS, whereas the alterations in motoneuron excitability and ionic currents (both 
transient and persistent) differ across transgenic models. To date, it is unfeasible to identify 
which of these alterations is an action of the disease (i.e., disease mechanism) or a reaction of 
the nervous system (i.e., compensatory mechanism) and more experiments are needed to 
elucidate the nature of these alterations. Computer simulations of realistic models of WT 
and mutant motoneurons allowed for the identification of hidden alteration in the 
biophysical properties of mutant motoneurons and demonstrated that synaptic efficacy is 
reduced in mutant motoneurons. It would be important to have extensive computational 
analysis of motoneuron properties in the various ALS transgenic models at various points in 
time during disease progression to identify and monitor the immeasurable changes in 
membrane properties of mutant motoneurons. This information would be expected to 
improve significantly our understanding of motoneuron pathophysiology in ALS.  
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